Simultaneous determination of alfentanil and midazolam in human plasma using liquid chromatography and tandem mass spectrometry.

Journal Article

A fast, sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of alfentanil and midazolam in human plasma has been developed and validated. Alfentanil and midazolam were extracted from plasma using a mixed-mode cation exchange solid phase extraction method, with recoveries of both compounds greater than 80% at 3 different concentrations (1, 10 and 100ng/ml). Compounds were analyzed on a C(18) column with a water and methanol mobile phase gradient with acetic acid as an additive, at a flow rate of 0.3ml/min. The working assay range was linear from 0.25 to 100ng/ml for each compound. The signal to noise ratio was 80 and 40 for alfentanil and midazolam, respectively, at the lowest concentration calibration standard, with less than 10% matrix suppression by human plasma at this concentration. Alfentanil and midazolam were stable in human plasma during storage at -80°C, processing, and analysis. The procedure was validated and applied to the analysis of plasma samples from healthy human subjects administered oral and intravenous alfentanil and midazolam.

Full Text

Duke Authors

Cited Authors

  • Kim, T; London, A; Kharasch, ED

Published Date

  • June 1, 2011

Published In

Volume / Issue

  • 55 / 3

Start / End Page

  • 487 - 493

PubMed ID

  • 21382685

Pubmed Central ID

  • 21382685

Electronic International Standard Serial Number (EISSN)

  • 1873-264X

Digital Object Identifier (DOI)

  • 10.1016/j.jpba.2011.01.040

Language

  • eng

Conference Location

  • England